Markets triggered the change in short-term trends after Nifty breached short-term support of 17,970 on Friday, thus activating a reversal with Bearish Pennant. The immediate reaction of Bearish Pennant should force prices to the lower end of the channel which is placed at 17,828 and below which, we may see a steep slide towards 16,800 in the near term. We expect Bank Nifty to test 38,000 in the coming days.
Nifty 50 Daily
Stocks to watch
Positive Read through
- GAIL plans to buy up to 26% equity stake in LNG projects in the United States.
- PNB to raise Rs 800 cr in AT1 bond, instrument has ‘AA+’ from India Ratings.
- NSE to include Adani Wilmar, and Adani Power in a few indices from March 31.
- HUL to sell Annapurna and Captain Cook brands for Rs 60 cr to Singapore co.
- AstraZeneca gets CDSCO nod for the drug to treat biliary tract cancer.
- Kotak Mahindra Bank was added to the FTSE index nine years after being removed.
- CRISIL garners 17.5% YoY growth in Q4 consolidated PAT; declares a final dividend.
- Samvardhana Motherson’s arm acquires 100 pct stake in SAS Autosystemtechnik for Euro 540 mn.
- Prince Pipes-Norges Bank Bought 9.02 Lac Shares At 585 worth Rs 53cr, Promoters Sold 21.5 Lac Shares.
- KEC International-New orders of 3023cr won the Single largest order to date of Rs. 2,060 crores.
- Indigo- Partnership with Turkish Airlines, 500 planes already on order from Airbus.
- Dilip Buildcon- Company bags order worth Rs 1,947 cr.
- Zydus Lifescience has received approval from the US health regulator to market Sirolimus tablets in America.
- RITES- Company bags new order worth Rs 76.08 cr.
Negative Read through
- Abbott Laboratories faces another FTC investigation over baby formula shortage.
- The CIPLA-Pithampur facility receives 8 observations under Form 483 by USFDA.
- United Breweries: MD & CEO Rishi Pardal resigns.
A financial planning platform where you can plan all your goals, cash flows, expenses management, etc., which provides you advisory on the go. Unbiased and with uttermost data security, create your Financial Planning at Rs. 1499/-
Disclaimer: The views shared in blogs are based on personal opinions and do not endorse the company’s views. Investment is a subject matter of solicitation and one should consult a Financial Adviser before making any investment using the app. Making an investment using the app is the investor’s sole decision, and the company or any of its communication cannot be held responsible for it.
